Grant of Option Clause Example with 21 Variations from Business Contracts

This page contains Grant of Option clauses in business contracts and legal agreements. An example clause is provided at the top of the page, followed by clauses with minor variations. You can view the text differences by selecting the "Show Differences" option.
Grant of Option. This agreement evidences the grant by Alnylam Pharmaceuticals, Inc,, a Delaware corporation (the "Company"), on , 20[ ] (the "Grant Date") to [ ], an employee of the Company (the "Participant"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company's 2009 Stock Incentive Plan (the "Plan"), a total of [ ] shares (the "Shares") of common stock, $.01 par value per share, of the Company ("Common Stock") at $[ ] per Share. Unless earlier terminated, this optio...n shall expire at 5:00 p.m., Eastern time, on [ ] (the "Final Exercise Date"). It is intended that the option evidenced by this agreement shall be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms. View More

Variations of a "Grant of Option" Clause from Business Contracts

Grant of Option. This agreement evidences the grant by Alnylam Pharmaceuticals, Inc,, Argos Therapeutics, Inc., a Delaware corporation (the "Company"), on , 20[ ] [ ], 20[__] (the "Grant Date") to [ ], an employee of the Company (the "Participant"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company's 2009 2014 Stock Incentive Plan (the "Plan"), a total of [ ] shares (the "Shares") of common stock, $.01 $0.001 par value per share, of the Company ("Common Stock") at an ...exercise price of $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ ] ], 20[__][10 years following the Grant Date] (the "Final Exercise Date"). It is intended that the option evidenced by this agreement shall be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms. View More
Grant of Option. This agreement (the "Agreement") evidences the grant by Alnylam Pharmaceuticals, Inc,, Endurance International Group Holdings, Inc., a Delaware corporation (the "Company"), on , [ ], 20[ ] (the "Grant Date") to [ ], an employee of the Company ] (the "Participant"), "Participant") of an option to purchase, in whole or in part, on the terms provided herein and in the Company's 2009 Constant Contact, Inc. Second Amended and Restated 2011 Stock Incentive Plan (the "Plan"), a total of [ ] shares (the... "Shares") of common stock, $.01 $0.0001 par value per share, of the Company ("Common Stock") at $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ ] (the "Final Exercise Date"). It is intended that the option evidenced by this agreement Agreement shall be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). "Code"), to the fullest extent permitted thereby. In the event any or all of this option shall not qualify as an incentive stock option, the portion that is not so qualified shall be deemed a non-incentive stock option. Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms. View More
Grant of Option. This agreement evidences the grant by Alnylam Spring Bank Pharmaceuticals, Inc,, Inc., a Delaware corporation (the "Company"), on [ , 20[ 20 ] (the "Grant Date") to [ ], an employee of the Company (the "Participant"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company's 2009 2014 Stock Incentive Plan (the "Plan"), a total of [ ] shares (the "Shares") of common stock, $.01 $0.0001 par value per share, of the Company ("Common Stock") at $[ ] per Share. U...nless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] (the "Final Exercise Date"). It is intended that the option evidenced by this agreement shall be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms. View More
Grant of Option. This agreement evidences the grant by Alnylam Pharmaceuticals, Inc,, Demandware, Inc., a Delaware corporation (the "Company"), on , 20[ ] (the 20 __(the "Grant Date") to [ ], , an employee of the Company (the "Participant"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company's 2009 2012 Stock Incentive Plan (the "Plan"), a total of [ ] shares (the "Shares") of common stock, $.01 $0.01 par value per share, of the Company ("Common Stock") at $[ ] $ per S...hare. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ ] (the , 20__(the "Final Exercise Date"). It is intended that the option evidenced by this agreement shall be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms. View More
Grant of Option. This agreement Agreement evidences the grant by Alnylam Pharmaceuticals, Inc,, PTC Therapeutics, Inc., a Delaware corporation (the "Company"), on , 20[ ] (the "Grant Date") to [ ], an employee , a director of the Company (the "Participant"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company's 2009 Stock 2013 Long-Term Incentive Plan (the "Plan"), a total of [ ] shares (the "Shares") of common stock, $.01 $0.001 par value per share, of the Company ("Co...mmon Stock") at $[ ] $ per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ ] (the "Final Exercise Date"). It is intended that the option evidenced by this agreement Agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms. View More
Grant of Option. This agreement evidences the grant by Alnylam Pharmaceuticals, Inc,, Visterra, Inc. a Delaware corporation (the "Company"), on , 20[ 200[ ] (the "Grant Date") to [ ], an employee [employee], [consultant], [director] of the Company (the "Participant"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company's 2009 2008 Stock Incentive Plan (the "Plan"), a total of [ ] shares (the "Shares") of common stock, $.01 $.0001 par value per share, of the Company ("Co...mmon Stock") at $[ ] $0.0001 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ ] (the "Final Exercise Date"). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms. View More
Grant of Option. This agreement (the "Agreement") evidences the grant by Alnylam Pharmaceuticals, Inc,, Endurance International Group Holdings, Inc., a Delaware corporation (the "Company"), on , [ ], 20[ ] (the "Grant Date") to [ ], an employee of the Company ] (the "Participant"), "Participant") of an option to purchase, in whole or in part, on the terms provided herein and in the Company's 2009 Constant Contact, Inc. Second Amended and Restated 2011 Stock Incentive Plan (the "Plan"), a total of [ ] shares (the... "Shares") of common stock, $.01 $0.0001 par value per share, of the Company ("Common Stock") at $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ ] (the "Final Exercise Date"). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms. View More
Grant of Option. This agreement Nonstatutory Stock Option Agreement (this "Agreement") evidences the grant by Alnylam Achillion Pharmaceuticals, Inc,, Inc. a Delaware corporation (the "Company"), on , [ ], 20[ ] (the "Grant Date") to [ ], an employee [employee][consultant][director] of the Company (the "Participant"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company's 2009 2015 Stock Incentive Plan (the (as amended and/or restated from time to time, the "Plan"), a to...tal of [ ] shares (the "Shares") of common stock, $.01 $0.001 par value per share, of the Company ("Common Stock") at $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ ] (the "Final Exercise Date"). It is intended that the option evidenced by this agreement Agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms. View More
Grant of Option. This agreement evidences the grant by Alnylam Pharmaceuticals, Inc,, Demandware, Inc., a Delaware corporation (the "Company"), on , 20[ ] 20 (the "Grant Date") to [ ], , an employee of the Company (the "Participant"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company's 2009 2012 Stock Incentive Plan (the "Plan"), a total of [ ] shares (the "Shares") of common stock, $.01 $0.01 par value per share, of the Company ("Common Stock") at $[ ] $ per Share. U...nless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ ] , 20 (the "Final Exercise Date"). It is intended that the option evidenced by this agreement shall be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms. View More
Grant of Option. This agreement Incentive Stock Option Agreement (this "Agreement") evidences the grant by Alnylam Achillion Pharmaceuticals, Inc,, Inc. a Delaware corporation (the "Company"), on , [ ], 20[ ] (the "Grant Date") to [ ], an employee of the Company (the "Participant"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company's 2009 2015 Stock Incentive Plan (the (as amended and/or restated from time to time, the "Plan"), a total of [ ] shares (the "Shares") of ...common stock, $.01 $0.001 par value per share, of the Company ("Common Stock") at $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ ] (the "Final Exercise Date"). It is intended that the option evidenced by this agreement Agreement shall be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms. View More